Enamine and Pcovery have extended their drug discovery collaboration that focuses on creating new drugs for treating invasive fungal infections.
Idifarma has invested over €300,000 in its facility in Spain in order to offer its customers automated capsule filling for commercial batches.
Wearable technology has been making inroads in the clinical trial industry, however several challenges and concerns surrounding lack of experience still stand in the way of increased adoption.
As Phase IV studies are ‘undergoing a revolution,’ a recent report suggests that medical affairs teams are apt to head post-marketing study strategy.
IDEA Pharma and Mass Innovation Labs have announced a new collaboration aimed at changing the way the pharma industry approaches innovation.
Patheon has bought a US API facility from Roche in a deal that will also see the CMO supply the Swiss firm with drug ingredients.
Vetter's new data processing center at its headquarters in Ravensburg, Germany has met all criteria required to meet the European DIN EN 50600 standard.
Content Provided by Reading Scientific Services Ltd.
Sometimes it's the smallest details that have the biggest impact on pharmaceutical performance. That's certainly true when it comes down to the properties of particles and their impact on pharmaceutical performance. Subtle changes in particle size, shape and distribution can have a major impact on pharmaceutical solubility, stability and efficacy.
Content Provided by World Courier
Southeast Asia is a growing pharmaceutical market, with a population of 620 million. What opportunities are there for multinational companies to access this rich area?